The American Journal of Managed Care

Inhaled Treprostinil Improves FVC in IPF Phase 3 Trial: Steven D. Nathan, MD

The phase 3 TETON-2 ( NCT05255991) clinical trial assessed inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) and ...
Pulmonology Advisor

GLI Race-Neutral Equations Linked to Lower Z-Scores in Black Children With BPD

Use of Global Lung Function Initiative race-neutral vs race-specific equations was associated with systematically lower z-scores in Black children with BPD.
Pulmonology Advisor

Anxiety and Depression Common in Idiopathic Pulmonary Fibrosis

Anxiety and depression are prevalent in patients with IPF and are linked to increased breathlessness and lower energy levels.
Healio

Nerandomilast lowers FVC decline in progressive pulmonary fibrosis at 52 weeks

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Oral nerandomilast doses of 9 mg and 18 mg were ...
Medscape

Less FVC Decline in Progressive PF With Oral Nerandomilast

SAN FRANCISCO — The investigational oral agent nerandomilast was superior to placebo at slowing the decline in forced vital capacity (FVC) among patients with progressive pulmonary fibrosis (PF), ...
Healio

Individuals with impaired FEV1/FVC trajectories often experience wheeze before middle age

Please provide your email address to receive an email when new articles are posted on . The most impaired lung function trajectories included rapid decline. Researchers found a link between rapidly ...
The American Journal of Managed Care

Inhaled Treprostinil Improves FVC in IPF TETON-1 Trial: Steven D. Nathan, MD

Recent results from the TETON-1 phase 3 clinical trial assessing inhaled treprostinil to treat idiopathic pulmonary fibrosis ...